{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:23:12Z","timestamp":1793946192918,"version":"4.8.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013831","name":"Universitatea de Medicin\u0103 \u015fi Farmacie din Craiova","doi-asserted-by":"publisher","award":["Article Processing Charges"],"award-info":[{"award-number":["Article Processing Charges"]}],"id":[{"id":"10.13039\/501100013831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04601-1","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:45:48Z","timestamp":1756295148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinicopathologic relevance of EpCAM and CD44 in pancreatic cancer: insights from a meta-analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Bogdan Silviu","family":"Ungureanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Ionut","family":"Gheonea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1374-276X","authenticated-orcid":false,"given":"Adina","family":"Turcu-Stiolica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pirici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristin-Constantin","family":"Vere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Fierut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Saftoiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"4601_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21037\/apc-24-2","volume":"7","author":"ES Christenson","year":"2024","unstructured":"Christenson ES, Yu R, Gai J, Wang H, Lei M, Zheng L. The impact of KRAS mutations on the clinical outcome and immune response following immunotherapy for pancreatic cancer. Ann Pancreat Cancer. 2024;7:6. https:\/\/doi.org\/10.21037\/apc-24-2.","journal-title":"Ann Pancreat Cancer"},{"issue":"8","key":"4601_CR2","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.3390\/ijms24087030","volume":"24","author":"R Bubin","year":"2023","unstructured":"Bubin R, Uljanovs R, Strumfa I. Cancer stem cells in pancreatic ductal adenocarcinoma. Int J Mol Sci. 2023;24(8):7030. https:\/\/doi.org\/10.3390\/ijms24087030.","journal-title":"Int J Mol Sci"},{"key":"4601_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/sci-2021-067","volume":"9","author":"V Sumbly","year":"2022","unstructured":"Sumbly V, Landry I. Understanding pancreatic cancer stem cells and their role in carcinogenesis: a narrative review. Stem Cell Investig. 2022;9:1. https:\/\/doi.org\/10.21037\/sci-2021-067.","journal-title":"Stem Cell Investig"},{"issue":"2","key":"4601_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/fcp.12521","volume":"34","author":"E Razi","year":"2020","unstructured":"Razi E, Radak M, Mahjoubin-Tehran M, Talebi S, Shafiee A, Hajighadimi S, Moradizarmehri S, Sharifi H, Mousavi N, Sarvizadeh M, Nejati M, Taghizadeh M, Ghasemi F. Cancer stem cells as therapeutic targets of pancreatic cancer. Fundam Clin Pharmacol. 2020;34(2):202\u201312. https:\/\/doi.org\/10.1111\/fcp.12521.","journal-title":"Fundam Clin Pharmacol"},{"issue":"18","key":"4601_CR5","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/ijms20184504","volume":"20","author":"S Zeng","year":"2019","unstructured":"Zeng S, P\u00f6ttler M, Lan B, Gr\u00fctzmann R, Pilarsky C, Yang H. Chemoresistance in pancreatic cancer. Int J Mol Sci. 2019;20(18):4504. https:\/\/doi.org\/10.3390\/ijms20184504.","journal-title":"Int J Mol Sci"},{"key":"4601_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/bs.acr.2023.02.007","volume":"159","author":"AM Palma","year":"2023","unstructured":"Palma AM, Bushnell GG, Wicha MS, Gogna R. Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma. Adv Cancer Res. 2023;159:343\u201372. https:\/\/doi.org\/10.1016\/bs.acr.2023.02.007.","journal-title":"Adv Cancer Res"},{"issue":"2","key":"4601_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrgastro.2014.1","volume":"11","author":"NJ Wood","year":"2014","unstructured":"Wood NJ. Pancreatic cancer: pancreatic tumour formation and recurrence after radiotherapy are blocked by targeting CD44. Nat Rev Gastroenterol Hepatol. 2014;11(2):73. https:\/\/doi.org\/10.1038\/nrgastro.2014.1.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"4601_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2174\/156652408786733667","volume":"8","author":"R Marhaba","year":"2008","unstructured":"Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M. CD44 and epcam: cancer-initiating cell markers. Curr Mol Med. 2008;8(8):784\u2013804. https:\/\/doi.org\/10.2174\/156652408786733667.","journal-title":"Curr Mol Med"},{"issue":"3","key":"4601_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10555-020-09898-3","volume":"39","author":"O Gires","year":"2020","unstructured":"Gires O, Pan M, Schinke H, Canis M, Baeuerle PA. Expression and function of epithelial cell adhesion molecule epcam: where are we after 40 years? Cancer Metastasis Rev. 2020;39(3):969\u201387. https:\/\/doi.org\/10.1007\/s10555-020-09898-3.","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"4601_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s001099900038","volume":"77","author":"M Balzar","year":"1999","unstructured":"Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med (Berl). 1999;77(10):699\u2013712. https:\/\/doi.org\/10.1007\/s001099900038.","journal-title":"J Mol Med (Berl)"},{"key":"4601_CR11","unstructured":"Di Paolo C, Willuda J, Kubetzko S, Lauffer I, Tschudi D, Waibel R, Pl\u00fcckthun A, Stahel RA, Zangemeister-Wittke U. A recombinant immunotoxin derived from a humanized epithelial cell adhesion molecule-specific single-chain antibody fragment has potent and selective antitumor activity. Clin Cancer Res. 2003;9(7):2837-48. Erratum in: Clin Cancer Res. 2004 Apr 1;10(7):2579."},{"issue":"1","key":"4601_CR12","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4081\/ejh.2022.3360","volume":"66","author":"D S\u00e1nchez-Ram\u00edrez","year":"2022","unstructured":"S\u00e1nchez-Ram\u00edrez D, Medrano-Guzm\u00e1n R, Candanedo-Gonz\u00e1lez F, De Anda-Gonz\u00e1lez J, Garc\u00eda-Rios LE, P\u00e9rez-Koldenkova V, Guti\u00e9rrez-de la Barrera M, Rodr\u00edguez-Enr\u00edquez S, Velasco-Vel\u00e1zquez M, Pacheco-Vel\u00e1zquez SC, Pi\u00f1a-S\u00e1nchez P, Mayani H, G\u00f3mez-Delgado A, Monroy-Garc\u00eda A, Mart\u00ednez-Lara AK, Montesinos JJ. High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma. Eur J Histochem. 2022;66(1):3360. https:\/\/doi.org\/10.4081\/ejh.2022.3360.","journal-title":"Eur J Histochem"},{"key":"4601_CR13","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ. 2021; 372, n71.","DOI":"10.1136\/bmj.n71"},{"issue":"1","key":"4601_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Reviews. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Reviews"},{"key":"4601_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"key":"4601_CR16","unstructured":"The Cochrane Collaboration. (2020). Review Manager (RevMan), Version 5.4. [Software]. Available at: https:\/\/training.cochrane.org\/online-learning\/core-software\/revman (Accessed: 15 December 2024)."},{"key":"4601_CR17","first-page":"15","volume":"1","author":"P Doebler","year":"2015","unstructured":"Doebler P, Holling H. Meta-analysis of diagnostic accuracy with Mada. R Packag. 2015;1:15.","journal-title":"R Packag"},{"issue":"3","key":"4601_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting Meta-Analyses in R with the metafor package. J Stat Softw. 2010;36(3):1\u201348. https:\/\/doi.org\/10.18637\/jss.v036.i03.","journal-title":"J Stat Softw"},{"issue":"4","key":"4601_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"\u015eK \u00c7orbac\u0131o\u011flu","year":"2023","unstructured":"\u00c7orbac\u0131o\u011flu \u015eK, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: A guide to interpreting the area under the curve value. Turk J Emerg Med. 2023;23(4):195\u20138. https:\/\/doi.org\/10.4103\/tjem.tjem_182_23.","journal-title":"Turk J Emerg Med"},{"key":"4601_CR20","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/sim.942","volume":"20","author":"CM Rutter","year":"2001","unstructured":"Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20:2865\u201384.","journal-title":"Stat Med"},{"key":"4601_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"4601_CR22","doi-asserted-by":"publisher","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials; 2007;8:16.https:\/\/doi.org\/10.1186\/1745-6215-8-16.","DOI":"10.1186\/1745-6215-8-16"},{"key":"4601_CR23","doi-asserted-by":"publisher","unstructured":"Akita H, Nagano H, Takeda Y, Eguchi H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Takahashi H, Ohigashi H, Tomita Y, Ishikawa O, Mori M, Doki Y. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity. Oncogene;2011;30(31):3468-76. https:\/\/doi.org\/10.1038\/onc.2011.59","DOI":"10.1038\/onc.2011.59"},{"issue":"2","key":"4601_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000341669","volume":"49","author":"S B\u00fcnger","year":"2012","unstructured":"B\u00fcnger S, Barow M, Thorns C, Freitag-Wolf S, Danner S, Tiede S, Pries R, G\u00f6rg S, Bruch HP, Roblick UJ, Kruse C, Habermann JK. Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissue. Eur Surg Res. 2012;49(2):88\u201398. https:\/\/doi.org\/10.1159\/000341669.","journal-title":"Eur Surg Res"},{"issue":"1","key":"4601_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/jcp.2006.037333","volume":"61","author":"D Fong","year":"2008","unstructured":"Fong D, Steurer M, Obrist P, Barbieri V, Margreiter R, Amberger A, Laimer K, Gastl G, Tzankov A, Spizzo G. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. J Clin Pathol. 2008;61(1):31\u20135. https:\/\/doi.org\/10.1136\/jcp.2006.037333.","journal-title":"J Clin Pathol"},{"issue":"5","key":"4601_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/his.12307","volume":"64","author":"D Fong","year":"2014","unstructured":"Fong D, Moser P, Kasal A, Seeber A, Gastl G, Martowicz A, Wurm M, Mian C, Obrist P, Mazzoleni G, Spizzo G. Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer. Histopathology. 2014;64(5):683\u201392. https:\/\/doi.org\/10.1111\/his.12307.","journal-title":"Histopathology"},{"key":"4601_CR27","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3892\/ijo.2012.1565","volume":"41","author":"S Kure","year":"2012","unstructured":"Kure S, Matsuda Y, Hagio M, Ueda J, Naito Z, Ishiwata T. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas. Int J Oncol. 2012;41:1314\u201324. https:\/\/doi.org\/10.3892\/ijo.2012.1565.","journal-title":"Int J Oncol"},{"issue":"12","key":"4601_CR28","first-page":"22204","volume":"8","author":"Y Meng","year":"2015","unstructured":"Meng Y, Xu BQ, Fu ZG, Wu B, Xu B, Chen ZN, Li L. Cytoplasmic EpCAM over-expression is associated with favorable clinical outcomes in pancreatic cancer patients with hepatitis B virus negative infection. Int J Clin Exp Med. 2015;8(12):22204\u201316.","journal-title":"Int J Clin Exp Med"},{"key":"4601_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/1471-2407-14-687","volume":"14","author":"T Mizukami","year":"2014","unstructured":"Mizukami T, Kamachi H, Mitsuhashi T, Tsuruga Y, Hatanaka Y, Kamiyama T, Matsuno Y, Taketomi A. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. BMC Cancer. 2014;14:687. https:\/\/doi.org\/10.1186\/1471-2407-14-687.","journal-title":"BMC Cancer"},{"issue":"2","key":"4601_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2220\/biomedres.34.87","volume":"34","author":"S Yonaiyama","year":"2013","unstructured":"Yonaiyama S, Toyoki Y, Morohashi S, Sakuraba S, Yoshizawa T, Suzuki T, Wu Y, Kijima H, Hakamada K. Epithelial cell adhesion molecule (EpCAM) overexpression is correlated with malignant potentials of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. Biomed Res. 2013;34(2):87\u201395. https:\/\/doi.org\/10.2220\/biomedres.34.87.","journal-title":"Biomed Res"},{"issue":"2","key":"4601_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3892\/or.2014.3245","volume":"32","author":"K Chen","year":"2014","unstructured":"Chen K, Li Z, Jiang P, Zhang X, Zhang Y, Jiang Y, He Y, Li X. Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma. Oncol Rep. 2014;32(2):755\u201363. https:\/\/doi.org\/10.3892\/or.2014.3245.","journal-title":"Oncol Rep"},{"issue":"10","key":"4601_CR32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/j.1349-7006.1998.tb00493.x","volume":"89","author":"T Gotoda","year":"1998","unstructured":"Gotoda T, Matsumura Y, Kondo H, Saitoh D, Shimada Y, Kosuge T, Kanai Y, Kakizoe T. Expression of CD44 variants and its association with survival in pancreatic cancer. Jpn J Cancer Res. 1998;89(10):1033\u201340. https:\/\/doi.org\/10.1111\/j.1349-7006.1998.tb00493.x.","journal-title":"Jpn J Cancer Res"},{"issue":"17","key":"4601_CR33","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1002\/cncr.28774","volume":"120","author":"YC Hou","year":"2014","unstructured":"Hou YC, Chao YJ, Tung HL, Wang HC, Shan YS. Coexpression of CD44-positive\/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma. Cancer. 2014;120(17):2766\u201377. https:\/\/doi.org\/10.1002\/cncr.28774.","journal-title":"Cancer"},{"issue":"4","key":"4601_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1369\/0022155411398275","volume":"59","author":"H Immervoll","year":"2011","unstructured":"Immervoll H, Hoem D, Steffensen OJ, Miletic H, Molven A. Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers. J Histochem Cytochem. 2011;59(4):441\u201355. https:\/\/doi.org\/10.1369\/0022155411398275.","journal-title":"J Histochem Cytochem"},{"key":"4601_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1746-1596-9-79","volume":"9","author":"Z Li","year":"2014","unstructured":"Li Z, Chen K, Jiang P, Zhang X, Li X, Li Z. CD44v\/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Diagn Pathol. 2014;9:79. https:\/\/doi.org\/10.1186\/1746-1596-9-79.","journal-title":"Diagn Pathol"},{"issue":"6","key":"4601_CR36","first-page":"6724","volume":"8","author":"XP Li","year":"2015","unstructured":"Li XP, Zhang XW, Zheng LZ, Guo WJ. Expression of CD44 in pancreatic cancer and its significance. Int J Clin Exp Pathol. 2015;8(6):6724\u201331.","journal-title":"Int J Clin Exp Pathol"},{"key":"4601_CR37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12957-015-0746-8","volume":"13","author":"L Xiaoping","year":"2015","unstructured":"Xiaoping L, Xiaowei Z, Leizhen Z, Weijian G. Expression and significance of CD44 and p-AKT in pancreatic head cancer. World J Surg Oncol. 2015;13:334. https:\/\/doi.org\/10.1186\/s12957-015-0746-8.","journal-title":"World J Surg Oncol"},{"key":"4601_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1746-1596-8-146","volume":"8","author":"G Zhou","year":"2013","unstructured":"Zhou G, Chiu D, Qin D, Niu L, Cai J, He L, Tan D, Xu K. Expression of CD44v6 and integrin-\u03b21 for the prognosis evaluation of pancreatic cancer patients after cryosurgery. Diagn Pathol. 2013;8:146. https:\/\/doi.org\/10.1186\/1746-1596-8-146.","journal-title":"Diagn Pathol"},{"issue":"1","key":"4601_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12885-021-08123-w","volume":"21","author":"G Askan","year":"2021","unstructured":"Askan G, Sahin IH, Chou JF, Yavas A, Capanu M, Iacobuzio-Donahue CA, Basturk O, O\u2019Reilly EM. Pancreatic cancer stem cells May define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma. BMC Cancer. 2021;21(1):385. https:\/\/doi.org\/10.1186\/s12885-021-08123-w.","journal-title":"BMC Cancer"},{"issue":"1","key":"4601_CR40","first-page":"832","volume":"10","author":"X Bao-Qing","year":"2017","unstructured":"Bao-Qing X, Meng Y, Fan XY, Ma LX, Qin J, Chen ZN, Li L. Membranous co-expression of EpCAM and CD44s predicts poor prognosis in pancreatic cancer patients. Int J Clin Med. 2017;10(1):832\u201342.","journal-title":"Int J Clin Med"},{"issue":"26","key":"4601_CR41","doi-asserted-by":"publisher","first-page":"18643","DOI":"10.1074\/jbc.M113.467787","volume":"288","author":"C Vannier","year":"2013","unstructured":"Vannier C, Mock K, Brabletz T, Driever W. Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development. J Biol Chem. 2013;288(26):18643\u201359. https:\/\/doi.org\/10.1074\/jbc.M113.467787.","journal-title":"J Biol Chem"},{"issue":"3","key":"4601_CR42","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-2030.","journal-title":"Cancer Res"},{"issue":"6","key":"4601_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.15698\/cst2019.06.188","volume":"3","author":"L Keller","year":"2019","unstructured":"Keller L, Werner S, Pantel K. Biology and clinical relevance of EpCAM. Cell Stress. 2019;3(6):165\u201380. https:\/\/doi.org\/10.15698\/cst2019.06.188.","journal-title":"Cell Stress"},{"key":"4601_CR44","doi-asserted-by":"publisher","first-page":"108374","DOI":"10.1016\/j.mrrev.2021.108374","volume":"787","author":"MM Gomari","year":"2021","unstructured":"Gomari MM, Farsimadan M, Rostami N, Mahmoudi Z, Fadaie M, Farhani I, Tarighi P. CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations. Mutat Res Rev Mutat Res. 2021;787:108374. https:\/\/doi.org\/10.1016\/j.mrrev.2021.108374.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"3","key":"4601_CR45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s1357-2725(97)00152-0","volume":"30","author":"H Ponta","year":"1998","unstructured":"Ponta H, Wainwright D, Herrlich P. The CD44 protein family. Int J Biochem Cell Biol. 1998;30(3):299\u2013305. https:\/\/doi.org\/10.1016\/s1357-2725(97)00152-0.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"4601_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/ijms21010336","volume":"21","author":"KL Chen","year":"2020","unstructured":"Chen KL, Li D, Lu TX, Chang SW. Structural characterization of the CD44 stem region for standard and Cancer-Associated isoforms. Int J Mol Sci. 2020;21(1):336. https:\/\/doi.org\/10.3390\/ijms21010336.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4601_CR47","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1053\/j.gastro.2021.08.023","volume":"161","author":"P Nallasamy","year":"2021","unstructured":"Nallasamy P, Nimmakayala RK, Karmakar S, Leon F, Seshacharyulu P, Lakshmanan I, Rachagani S, Mallya K, Zhang C, Ly QP, Myers MS, Josh L, Grabow CE, Gautam SK, Kumar S, Lele SM, Jain M, Batra SK, Ponnusamy MP. Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1-CD44 axis. Gastroenterology. 2021;161(6):1998\u2013e20137. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.023.","journal-title":"Gastroenterology"},{"issue":"4","key":"4601_CR48","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1053\/j.gastro.2013.12.035","volume":"146","author":"L Li","year":"2014","unstructured":"Li L, Hao X, Qin J, Tang W, He F, Smith A, Zhang M, Simeone DM, Qiao XT, Chen ZN, Lawrence TS, Xu L. Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice. Gastroenterology. 2014;146(4):1108\u201318. https:\/\/doi.org\/10.1053\/j.gastro.2013.12.035.","journal-title":"Gastroenterology"},{"issue":"3","key":"4601_CR49","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1172\/JCI44540","volume":"121","author":"RL Brown","year":"2011","unstructured":"Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, Cheng C. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest. 2011;121(3):1064\u201374. https:\/\/doi.org\/10.1172\/JCI44540.","journal-title":"J Clin Invest"},{"issue":"3","key":"4601_CR50","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stem.2014.01.009","volume":"14","author":"M Todaro","year":"2014","unstructured":"Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M, Apuzzo T, Sperduti I, Volpe S, Cocorullo G, Gulotta G, Dieli F, De Maria R, Stassi G. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 2014;14(3):342\u201356. https:\/\/doi.org\/10.1016\/j.stem.2014.01.009.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4601_CR51","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/hed.20544","volume":"29","author":"SJ Wang","year":"2007","unstructured":"Wang SJ, Wreesmann VB, Bourguignon LY. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head Neck. 2007;29(6):550\u20138. https:\/\/doi.org\/10.1002\/hed.20544.","journal-title":"Head Neck"},{"key":"4601_CR52","doi-asserted-by":"publisher","unstructured":"Xu Y, Bai Z, Lan T, Fu C, Cheng P. CD44 and its implication in neoplastic diseases. MedComm (2020). 2024;5(6):e554. https:\/\/doi.org\/10.1002\/mco2.554","DOI":"10.1002\/mco2.554"},{"issue":"22","key":"4601_CR53","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1158\/1078-0432.CCR-15-3115","volume":"22","author":"S Zhao","year":"2016","unstructured":"Zhao S, Chen C, Chang K, Karnad A, Jagirdar J, Kumar AP, Freeman JW. CD44 expression level and isoform contributes to pancreatic cancer cell plasticity, invasiveness, and response to therapy. Clin Cancer Res. 2016;22(22):5592\u2013604. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-3115.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4601_CR54","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11(1):64. https:\/\/doi.org\/10.1186\/s13045-018-0605-5.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"4601_CR55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/1724600817746951","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wu T, Lu D, Zhen J, Zhang L. CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer. Int J Biol Markers. 2018;33(3):308\u201313. https:\/\/doi.org\/10.1177\/1724600817746951.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"4601_CR56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12975-012-0251-0","volume":"4","author":"SP Yu","year":"2013","unstructured":"Yu SP, Wei Z, Wei L. Preconditioning strategy in stem cell transplantation therapy. Transl Stroke Res. 2013;4(1):76\u201388. https:\/\/doi.org\/10.1007\/s12975-012-0251-0.","journal-title":"Transl Stroke Res"},{"issue":"4","key":"4601_CR57","doi-asserted-by":"publisher","first-page":"e0175357","DOI":"10.1371\/journal.pone.0175357","volume":"12","author":"M Dai","year":"2017","unstructured":"Dai M, Yuan F, Fu C, Shen G, Hu S, Shen G. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis. PLoS ONE. 2017;12(4):e0175357. https:\/\/doi.org\/10.1371\/journal.pone.0175357.","journal-title":"PLoS ONE"},{"key":"4601_CR58","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ijsu.2018.06.025","volume":"56","author":"L Zhou","year":"2018","unstructured":"Zhou L, Zhu Y. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis. Int J Surg. 2018;56:274\u201380. https:\/\/doi.org\/10.1016\/j.ijsu.2018.06.025.","journal-title":"Int J Surg"},{"issue":"4","key":"4601_CR59","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.21037\/apm-20-2013","volume":"10","author":"T Zhu","year":"2021","unstructured":"Zhu T, Peng X, Cheng Z, Xing D, Zhang M. Diagnostic rather than prognostic markers-relationship between EpCAM overexpression and lung cancer: a meta-analysis. Ann Palliat Med. 2021;10(4):4025\u201336. https:\/\/doi.org\/10.21037\/apm-20-2013.","journal-title":"Ann Palliat Med"},{"issue":"6","key":"4601_CR60","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.21873\/invivo.11411","volume":"32","author":"CP Hsu","year":"2018","unstructured":"Hsu CP, Lee LY, Hsu JT, Hsu YP, Wu YT, Wang SY, Yeh CN, Chen TC, Hwang TL. CD44 predicts early recurrence in pancreatic cancer patients undergoing radical surgery. Vivo. 2018;32(6):1533\u201340. https:\/\/doi.org\/10.21873\/invivo.11411.","journal-title":"Vivo"},{"issue":"2","key":"4601_CR61","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.gastro.2015.10.020","volume":"150","author":"A Matzke-Ogi","year":"2016","unstructured":"Matzke-Ogi A, Jannasch K, Shatirishvili M, Fuchs B, Chiblak S, Morton J, Tawk B, Lindner T, Sansom O, Alves F, Warth A, Schwager C, Mier W, Kleeff J, Ponta H, Abdollahi A, Orian-Rousseau V. Inhibition of tumor growth and metastasis in pancreatic cancer models by interference with CD44v6 signaling. Gastroenterology. 2016;150(2):513\u2013e2510. https:\/\/doi.org\/10.1053\/j.gastro.2015.10.020.","journal-title":"Gastroenterology"},{"key":"4601_CR62","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3389\/fonc.2019.01359","volume":"9","author":"W Mu","year":"2019","unstructured":"Mu W, Wang Z, Z\u00f6ller M. Ping-Pong-Tumor and host in pancreatic cancer progression. Front Oncol. 2019;9:1359. https:\/\/doi.org\/10.3389\/fonc.2019.01359.","journal-title":"Front Oncol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04601-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04601-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04601-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:21:22Z","timestamp":1757442082000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04601-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4601"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04601-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"463"}}